Sloan-Kettering Institute

In more than 100 laboratories, our scientists are conducting innovative research to advance understanding in the biological sciences and improve human health.

Learn more »
Pictured: Zuckerman Research Center Growing Science: A Decade Devoted to Advancing Cancer Research at the Sloan-Kettering Institute »

Lab Heads

Select...
Allis, David
Funabiki, Hironori
Ryan, Timothy A.
Weinstein, Harel
Pictured: Three-dimensional structure of the protein mTOR
A Recently Revealed Protein Structure Creates New Opportunities for Cancer Research and Drug Design

In an eagerly awaited study, Memorial Sloan-Kettering researchers report on the molecular structure of mTOR, a protein commonly mutated in cancer.

Pictured: Three-dimensional structure of the protein mTOR
Pictured: Melanocytes
Pigment-Producing Skin Cells Generated Using Stem Cell Technology

Memorial Sloan-Kettering researchers have developed innovative ways to study some skin diseases, including melanoma skin cancer.

Pictured: Melanocytes
Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.

Pictured: Isabelle Rivière, Michel Sadelain & Renier Brentjens
Pictured: ESK1 Monoclonal Antibody
New Molecule Targets Proteins Inside Cancer Cells

Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.

Pictured: ESK1 Monoclonal Antibody

Upcoming Programs & Events

Seminar
Sloan-Kettering Institute Scientific Colloquium
Thursday, June 20, 2013 - 4:30 PM – 5:30 PM
Seminar
From Microbial Surveys to Mechanisms of Interaction in the Human Microbiome
Thursday, June 20, 2013 - 10:30 PM – 11:30 PM
See all »